Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin +/- 5-FU in Endometrial Cancer
NCT00612495Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in endometrial cancer (EC), sponsored by Sanofi. Started Jan 2001; status: completed.
02
Drugs
oxaliplatin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00612495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612495.